Skip to Content

A112 (Desvenlafaxine Succinate Extended-Release 25 mg (base))

Pill with imprint A112 is Pink, Four-sided and has been identified as Desvenlafaxine Succinate Extended-Release 25 mg (base). It is supplied by Actavis Pharma, Inc..

Desvenlafaxine is used in the treatment of major depressive disorder; depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 25 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for A112

Desvenlafaxine succinate extended-release 25 mg (base) A112

Desvenlafaxine Succinate Extended-Release

Imprint
A112
Strength
25 mg (base)
Color
Pink
Size
9.00 mm
Shape
Four-sided
Availability
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-4060
Inactive Ingredients
hypromelloses, microcrystalline cellulose, magnesium silicate, magnesium stearate, silicon dioxide, titanium dioxide, ferric oxide yellow, ferric oxide red, propylene glycol, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "A112"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.